Mariner
HRMY icon

Mariner’s Harmony Biosciences HRMY Stock Holding History

Mariner’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
41,750
+16,635
+66% +$525K ﹤0.01% 1657
2026
Q1 		$703K Sell
25,115
-1,151
-4% -$37.7K ﹤0.01% 2236
2025
Q4 		$983K Buy
+26,266
New +$864K ﹤0.01% 1962

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mariner's HRMY Position: Q2 2026 in Review

Mariner increased its Harmony Biosciences (HRMY) stake by 66% in Q2 2026, buying an estimated $525K and bringing the position to 41,750 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1657.

Mariner first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Mariner held 41,750 shares of Harmony Biosciences worth $1.52M as of Q2 2026.
  • Mariner bought 16,635 Harmony Biosciences shares in Q2 2026, an estimated $525K.
  • Harmony Biosciences made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1657 holding.
  • Mariner first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.